- MYGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $33.8 million.
- MYGN has traded 113,459 shares today.
- MYGN is down 3.1% today.
- MYGN was up 6.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MYGN with the Ticky from Trade-Ideas. See the FREE profile for MYGN NOW at Trade-Ideas More details on MYGN: Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. MYGN has a PE ratio of 15.9. Currently there are 4 analysts that rate Myriad Genetics a buy, 2 analysts rate it a sell, and 8 rate it a hold. The average volume for Myriad Genetics has been 1.2 million shares per day over the past 30 days. Myriad has a market cap of $2.8 billion and is part of the services sector and diversified services industry. The stock has a beta of 0.93 and a short float of 54% with 44.17 days to cover. Shares are up 92.6% year-to-date as of the close of trading on Monday.